These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
604 related items for PubMed ID: 3027168
1. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. Rook AH, Lane HC, Folks T, McCoy S, Alter H, Fauci AS. J Immunol; 1987 Feb 15; 138(4):1064-7. PubMed ID: 3027168 [Abstract] [Full Text] [Related]
2. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. Ljunggren K, Böttiger B, Biberfeld G, Karlson A, Fenyö EM, Jondal M. J Immunol; 1987 Oct 01; 139(7):2263-7. PubMed ID: 3498755 [Abstract] [Full Text] [Related]
3. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells. Ruscetti FW, Mikovits JA, Kalyanaraman VS, Overton R, Stevenson H, Stromberg K, Herberman RB, Farrar WL, Ortaldo JR. J Immunol; 1986 May 15; 136(10):3619-24. PubMed ID: 2422259 [Abstract] [Full Text] [Related]
4. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. Yarchoan R, Redfield RR, Broder S. J Clin Invest; 1986 Aug 15; 78(2):439-47. PubMed ID: 3016028 [Abstract] [Full Text] [Related]
6. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. Ojo-Amaize EA, Nishanian P, Keith DE, Houghton RL, Heitjan DF, Fahey JL, Giorgi JV. J Immunol; 1987 Oct 01; 139(7):2458-63. PubMed ID: 2821115 [Abstract] [Full Text] [Related]
7. [Is the HTLV III/LAV virus the causative agent of AIDS or merely an agent of one of the opportunistic infections?]. Hollán Z. Orv Hetil; 1986 Dec 28; 127(52):3219-20. PubMed ID: 2949193 [No Abstract] [Full Text] [Related]
8. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. Tyler DS, Stanley SD, Nastala CA, Austin AA, Bartlett JA, Stine KC, Lyerly HK, Bolognesi DP, Weinhold KJ. J Immunol; 1990 May 01; 144(9):3375-84. PubMed ID: 2329275 [Abstract] [Full Text] [Related]
9. Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies. Marquart KH, Müller HA, Hartter P, Oku JC, Ayuko WO. J Trop Med Hyg; 1987 Apr 01; 90(2):93-4. PubMed ID: 3470530 [Abstract] [Full Text] [Related]
10. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Shearer GM, Salahuddin SZ, Markham PD, Joseph LJ, Payne SM, Kriebel P, Bernstein DC, Biddison WE, Sarngadharan MG, Gallo RC. J Clin Invest; 1985 Oct 01; 76(4):1699-704. PubMed ID: 2997287 [Abstract] [Full Text] [Related]
11. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan. Ikegami N. AIDS Res; 1986 Dec 01; 2 Suppl 1():S29-34. PubMed ID: 3103640 [Abstract] [Full Text] [Related]
12. Human retroviral env and gag polypeptides: serologic assays to measure infection. Kanner SB, Cheng-Mayer C, Geffin RB, Parks WP, Beltz GA, Arthur LO, Samuel KP, Papas TS. J Immunol; 1986 Jul 15; 137(2):674-8. PubMed ID: 3014000 [Abstract] [Full Text] [Related]
13. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia. Knutsen AP, Bouhasin JD, Lawrence DN, Roodman ST, Mueller KR, McDougal JS, Joist JH. Ann Allergy; 1986 Nov 15; 57(5):376-84. PubMed ID: 2946253 [Abstract] [Full Text] [Related]
14. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. Margolick JB, Volkman DJ, Folks TM, Fauci AS. J Immunol; 1987 Mar 15; 138(6):1719-23. PubMed ID: 3493285 [Abstract] [Full Text] [Related]
15. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. McDougal JS, Mawle A, Cort SP, Nicholson JK, Cross GD, Scheppler-Campbell JA, Hicks D, Sligh J. J Immunol; 1985 Nov 15; 135(5):3151-62. PubMed ID: 2995487 [Abstract] [Full Text] [Related]
16. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection. Sarngadharan MG, diMarzo Veronese F, Lee S, Gallo RC. Cancer Res; 1985 Sep 15; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106 [Abstract] [Full Text] [Related]
17. [Immunization against the human immunodeficiency virus in Zaire]. Zagury D, Salaün JJ, Bernard J, Dechazal L, Goussard B, Lurhuma Z. Med Trop (Mars); 1988 Sep 15; 48(4):417-23. PubMed ID: 3221792 [Abstract] [Full Text] [Related]
18. Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania. Schüpbach J, Tanner M. Acta Trop; 1986 Sep 15; 43(3):195-206. PubMed ID: 2877546 [Abstract] [Full Text] [Related]
19. HTLV and immunosuppression. Essex M, Kanki P, Allan J, Barin F, McLane MF, Lee TH, Kitchen L, Homma T, Malone G, Yokota T. Princess Takamatsu Symp; 1984 Sep 15; 15():309-18. PubMed ID: 6100649 [Abstract] [Full Text] [Related]